SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " investment " 1,928 found 🔀 AI-powered Shuffle
William O'Dowd IV Discloses Investment at Dolphin Entertainment with 19.0% Stake
William O'Dowd IV, the CEO of Dolphin Entertainment, Inc., reported beneficial ownership of 19.0% of the company's common stock. He filed a Schedule 13D on Sep. 08, 2026, after an earlier note exchange and a pre-set buying plan in 2025. The position includes common shares and the right to convert c…
Colisée’s new owners pledge to ‘bring life back’ to Lewiston’s top entertainment, sports venue
The New York-based owners say the sale signifies a serious future investment in professional hockey in the city, as well as youth hockey, community events and more.
Rogers mixed-income community opens after $13 million investment
Three-story, 60-unit Olive Street Apartments recently opened at 700 N. 24th St. in Rogers. Roughly $13 million was invested in the attainable housing project, supported by the Walton Family Foundation....
Exclusive: Two of gaming’s biggest names are making a big investment in gaming’s future
The first thing to know about the Nova Games Foundation is that it isn’t about The Game Awards. And it’s not about PlayStation. The ambitious new grant program is the brainchild of Geoff Keighley and Mark Cerny. Keighley is the host of The Game Awards, Summer Game Fest and Opening Night Live. Cerny is a game designer of some 45 years and the lead architect for the PlayStation 4 and 5. But this new thing, which they’re revealing through Game File, isn’t about their day jobs. It’s an unaffiliated, standalone philanthropic project. It’s a bet on the artistic future of video games and a way, they tell me, to give back. “I’m nearing the end of my career,” Cerny recently told me over email. “I’m not done yet, but paying it forward—in the best way possible—is very much on my mind these days,” The Nova Games Foundation is a university-affiliated fellowship program, intended to offer six-figure grants to 20 young game designers each year, potentially for decades to come. It will offer no-strings-attached funding along with mentorship from games industry leaders, a combination intended to aid the development of groundbreaking new games, Cerny and Keighley told me. Nova will begin accepting applications in December, from class of 2026 and 2027 students from 13 affiliated gaming programs at universities in eight countries. The schools working with Nova include the New York University and the University of Southern California in the U.S., along with Abertay University in Scotland, Cnam-Enjmin in France, TH Köln in Germany, and the Royal Melbourne Institute of Technology in Australia, Cerny and Keighley said. The plan: $100,000 per recipient, with about a quarter of Nova fellows eligible for up to $500,000 more for projects that are shaping up particularly well. Payments will be delivered based on development milestones, and recipients will own their games. Nova will help promote the work, and developers will be free to pursue the publishers and platforms of their choice. Nova can help introduce fellows to publishers, but won’t take a cut. “I’ve always wanted to give back, but given my role in the industry, I’ve never felt it appropriate to commercially invest in games,” Keighley told Game File. “I’ve never owned stock in a game company or taken a financial stake in a game. Nova is philanthropy: we aren’t taking equity or looking to recoup the grants. The return we’re hoping for is creative—helping new voices make games and find their footing. “Mark and I have each made multi-million-dollar donations to establish the foundation, and we intend to keep contributing. We hope others will join us.” Cerny and Keighley have already hired an executive director, John Maconga, and a head of grants, recent Game Developers Conference director Ashley Corrigan, to help launch the effort. They’re working to recruit game industry leaders to join the effort. Keighley says “dozens of leading game directors have already expressed interest in contributing their time.” To name one, they’ve already gotten Josef Fares, lead designer from It Takes Two and Spit Fiction studio Hazelight on board with a donation and pledge to help out. “I’m proud to support Nova because it gives the next generation of creators the freedom to explore their creativity and hopefully bring their unique visions to life,” Fares told Game File. A plan forged from a friendship Keighley and Cerny have known each other a long time. It’s been so long, Cerny isn’t even sure exactly when they met. “We travel in much the same circles and I’m sure first intersected in the 90s or early 2000s,“ Cerny said. Keighley thinks it might have been during his stint writing a column about the mid-’90s console 3DO for a gaming magazine while Cerny was working on games with Crystal Dynamics or on Way of the Warrior with Naughty Dog. They became genuine friends about a 10 years ago, Keighley said, as they bonded over a shared love of games and a hope to improve the industry. “About a decade ago, we started having dinner a few times a year in LA,” Keighley said. “Just to catch up on life and the industry. Those conversations continued over Zoom during COVID. Nova grew out of that friendship and a question we kept coming back to: ‘What could we do to help the next generation of game directors get started?’” Keighley credits Cerny with the idea to figure out a way to put their money and time back into the industry. At one of those dinners, Keighley proposed the idea of a fellowship program. He’d recalled applying for a Rhodes Scholarship when he was younger. “Spoiler: I didn’t get it,” he said. He’d admired the MacArthur Foundation’s so-called “genius grants.” He liked these kinds of programs that recognized people’s talents and gave them the financial boost and the freedom to realize their potential. With Cerny, he had pondered what a game industry version of that could be. Keighley liked the idea of centering the fellowship on students, drawing inspiration from the accomplishments of Jenova Chen, the USC game design graduate who went on to lead the creation of gently moving, ambitious games such as Flower and Journey. Keighley also thought it could be useful to help promising graduates bridge the transition from student to professional. “Joining an established studio isn’t always possible—especially in today’s market—and even then, it isn’t the right path for everyone,” Keighley said. A fellowship, he realized, could give “graduates the time, resources and guidance to pursue a game of their own and not worry about the commercial viability.” As the idea took shape, Cerny also saw an opportunity to enable more games of a certain type: “The target with the grants is games as an artistic medium,” Cerny told me. “We like to say games with ‘artistic, literary and societal value.’” He added: “I’m a pretty big gamer myself, though I tend to gravitate towards the smaller and more unique or artistic titles, games like Neva, Abzu, Gorogoa, Stray or Outer Wilds. I was just playing and Roger on a flight to Japan, and was getting misty eyed to a degree that I was concerned that a flight attendant would ask me if I was OK. “So one fun benefit here is the games that will come out of the Nova Games Foundation – I can’t wait to play them myself.” Cerny believes it will also be useful for Nova fellows to hone their craft and team leadership skills. “We are looking for the next generation of visionaries,” he said. “The trick is that they will also need to have the executive function necessary to drive a small project to completion.” Game File is a reader-supported publication. To receive new posts and support my reporting, please consider becoming a free or paid subscriber. Subscribe Going big with this Keighley and Cerny may have started Nova and may be the ones primarily backing it right now, but they’re dreaming of something that goes beyond them. “Mark and I may have helped get it started, but one of our measures of success is that Nova grows into something the entire games industry feels a sense of ownership in,” Keighley said. “Our ambition is to build a lasting endowment supported by people and companies across the industry, and an equally broad community of creators willing to give their time and experience to the next generation.” The industry has a lot of knowledge that it can pass to the next generation, Keighley said: “Nova can hopefully become a way to connect that generosity with talented young creators at the moment when it can make the biggest difference.” Cerny, who told me he believes Nova can mature “over the next 10 or 20 years,” sees an opportunity to give generations of game makers momentum. “The industry has changed immeasurably since I started in games in 1982,” he said. “These graduates have talent, training and tools that outclass what we had back in the day by an astonishing amount. But they face a tough road ahead getting traction in the industry, and many could benefit from our support. We want to be there to give it to them.” “There’s a personal side to this, too,” Keighley said. “I don’t have children, and I’ve spent a lot of time thinking about what I can do for future generations. Games have been my entire career. I’ve been incredibly fortunate, and helping someone else build a life in this industry feels like a meaningful way to give back.” Cerny’s oeuvre dates back to Marble Madness and Sonic the Hedgehog 2. He has stood on stage multiple times to reveal the future of PlayStation hardware. He’s been an executive producer for a string of modern PlayStation classics such as The Last Guardian and Marvel’s Spider-Man. Nevertheless, of Nova, he said, “It’s certainly not like anything I’ve done before.” Nova Foundation applications will be due in December and the first wave of fellows will be announced in March 2027. A full list of participating universities and steps students and recent graduates can take to apply to become a Nova Fellow is forthcoming.
Ariel Investments names new leadership for private equity unit
The firm named Rodney Cohen co-CEO of Ariel Alternatives alongside Mellody Hobson.
Louisiana concrete companies join forces to capitalize on construction boom
Two Louisiana concrete suppliers are joining forces with two out-of-state companies to pursue large-scale construction projects as billions of dollars in new industrial and technology investment move … Already an INSIDER? Sign in. Already an INSIDER? Sign in
UnitedHealth’s Democrat investment, and surprise billing bloat debate
UnitedHealth execs shower a top Democrats with cash, and the No Surprises Act debate heats up.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
What Makes Guardant Health (GH) a Compelling Bet?
Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]
Memorial Hermann Health System Deepens Partnership with Strategic Investment in PartsSource
Check out today's featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“Optimi” or the “Company”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The conference will be held September 14-16, 2026, at the Lotte New York Palace Hotel. A Company presentation will be available on demand here beginning Friday, Septem
Cricket Australia opens Big Bash to privatisation
Cricket Australia opens the Big Bash to private investment - with some owners of franchises in The Hundred showing interest.
Qualitas Energy buys Cero Generation’s 5.8GW European renewables business
Renewables investment platform Qualitas Energy has bought Cero Generation’s 5.8GW European solar PV and energy storage project portfolio.
Colombia business association labels hydrogen a $20bn ‘investment opportunity’
The National Business Association of Colombia (ANDI) believes the country’s hydrogen sector is an “investment opportunity worth over $20bn,” saying a pipeline of announced projects could attract enormous capital.
Gayle Benson buys another well-known New Orleans skyscraper, adding to growing property holdings
“There is tremendous opportunity in New Orleans, and investment creates confidence, confidence creates opportunity, and opportunity creates jobs and economic growth," Benson said. "We want to be part of that process and continue doing our part."
UT Health San Antonio invests $1 billion to meet the growing demand for healthcare in South Texas
The multiyear investment strengthens patient care, research and healthcare infrastructure.
EU seeks to reassure a Trump-rattled Greenland with promise of a new partnership and investment
The European Union is promising Greenland a stronger partnership and hundreds of millions of euros in investment, wanting to reassure Greenland after U.S. President Donald Trump's threats to take control of the island.
WHO Health Emergencies EPI-WIN webinar: Strengthening pandemic preparedness: from investment to implementation and impact
Pandemic prevention, preparedness and response (PPR) requires sustained investment to build and maintain the capacities needed to detect, prevent and respond to health emergencies. This webinar will explore practical experiences from country and regional initiatives, highlighting lessons learned on translating investments into stronger preparedness systems and more resilient health security capacities.
EU chief unveils $232 million Greenland package
The European Union seeks to boost its relations with the vast island
Global Growth Fund is Re-Evaluating Flutter Entertainment’s (FLUT) Strategic Fit
Sands Capital, an investment management company, released its second-quarter 2026 investor letter for “Sands Capital Global Growth Fund”. The letter can be downloaded here. Global Growth seeks the best growth businesses worldwide, leveraging a research team that explores both developed and emerging markets for sustainable competitive advantages. In the quarter, global equities rebounded strongly, driven […]
CREDA poll: New Mexico’s gross receipt tax makes it hard to do business
Some developers said New Mexico’s gross receipts tax makes the state less competitive than its neighbors. They believe tax reform for new construction would go a long way in attracting new development and investment.
Why employee mental health is your best investment
Wedgwood expert Brina Tiemeyer explains how mental health support, strong managers and healthy workplace cultures strengthen the workforce.
Why employee mental health is your best investment
Wedgwood expert Brina Tiemeyer explains how mental health support, strong managers and healthy workplace cultures strengthen the workforce.
'Black Swan' investor predicts AI boom ends with crash of a lifetime
Universa Investments' Mark Spitznagel told BI that he expects one more "euphoric rally" followed by a "bigger crash than we've seen in our lifetime."
Pittsburgh orders 13 fire trucks backed by Highmark Health
Pittsburgh has ordered 13 new fire apparatuses as part of a public safety investment supported by Highmark Health.
One in five Americans call sports betting an investment. For Gen Z, it’s twice as many — and they don’t come close to breaking even
People used to place bets periodically, but now it has become a daily habit for nearly a quarter of sports bettors.
Von der Leyen visits Greenland amid Trump pressure
The EU is preparing a major investment package and closer political ties with the Danish Arctic territory amid Donald Trump's demand for greater US control of the mineral-rich island.
Zinc: British Business Bank Commits Up To £46 Million To Science-For-Impact Fund
The British Business Bank has agreed to commit up to £46 million to Zinc Capital Management's Science-for-Impact Fund, providing a cornerstone investment for the early-stage venture fund focused on UK deep tech companies addressing health and environmental challenges.
Phnom Penh recognised with WHO Healthy Cities Award for safer, healthier urban mobility
Phnom Penh City Hall has been awarded the World Health Organization (WHO) Healthy Cities Recognition Awards 2026 in the Safe, Active and Health-enabling Transport category, recognising its commitment to improving road safety and creating healthier urban mobility for residents. The award was presented during the 11th Global Conference of the Alliance for Healthy Cities held in Sydney, Australia, from 1-3 September 2026. Phnom Penh was recognised for the project “Safe, Active and Health-enabling Transport: Advancing Health and Reducing Inequities in Urban Mobility”, supported through the Partnership for Healthy Cities. The initiative has focused on creating safer and more accessible environments for vulnerable road users, particularly around schools. The project combines road safety data, infrastructure improvements, 30 km/h speed management, enforcement, education and community engagement to address risks around high-risk schools. Improvements have included the installation of traffic signs and road markings, smart speed limit signs, safety camera systems and strengthened monitoring in school zones. At the two intervention schools, infrastructure conditions improved from 1.0-star rating to 4.2 and 3.5 stars using the Star Rating for Schools tool. The project also contributed to lower vehicle speeds, provided road safety training for 500 students and achieved a reported 58% reduction in self-reported crashes. iRAP was proud to serve as the technical advisor to the project, supporting evidence-based approaches to infrastructure safety and helping to guide interventions that protect people walking, cycling and travelling to and from school. The WHO recognition is particularly significant given the strong level of regional participation. More than 150 cities from across the Asia-Pacific region applied for the awards, with only eight cities ultimately selected for recognition. The award demonstrates how targeted investment in safer roads and sustainable transport can contribute to healthier, more equitable cities while supporting broader goals for urban development and quality of life. iRAP congratulates the Phnom Penh City Hall and all project partners on this important achievement and looks forward to continuing to support initiatives that deliver safer roads and safer journeys for everyone. Read original article hereRead more on the project here
The Second Global Business Summit on BRI Infrastructure to Accelerate the SDGs Held in Singapore
/PRNewswire/ -- The Second Global Business Summit on Belt and Road Infrastructure Investment to Accelerate the SDGs was held in Singapore under the theme...
3 Stocks Tied To Rising HSA Use Including CVS Health Stock
Health Savings Accounts are quietly becoming a core part of how Americans pay for care, with more employers auto enrolling workers and pairing HSAs with high deductible health plans. That shift channels more money through platforms that handle contributions, custody, and investments. For investors, the question is which stocks may benefit most from this structural change. This article walks through three HSA exposed stocks from our screener and what the news could mean for each. The three...
Is UT Tyler Specialty Expansion Reframing the Investment Case for Ardent Health (ARDT)?
Ardent Health recently marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the UT Tyler School of Medicine Building in Tyler, bringing women’s health, pulmonary, orthopedic, imaging and surgical services alongside the region’s first medical school. This integration of patient care and physician training, supported by more than US$315 million of capital investment since 2018 and a provider network that has grown by 116%, underscores Ardent’s...
Apollo’s €3bn Bayer deal shows ‘non-control’ financing is spreading to operators
Apollo’s €3bn Bayer LARC investment and a $35bn Broadcom financing highlight how private credit is funding AI and industrial capex without operators giving up c
SAP bets on AI to recover from SaaSpocalypse downturn
SAP executive Jan Gilg discusses the SaaSpocalypse impact and its AI investments. It's been competing more with Palantir and other AI companies.
Dealroom.co | Chengdu Leen Automation lands early-stage backing from Chengdu Science and Technology Innovation Investment
What's the deal? Chengdu Leen Automation Technology has raised a…
Durham offers $10K for Fayetteville Street businesses, but owners say corridor needs more investment
Durham's Bounce Back program is providing grants and business support to help small businesses along Fayetteville Street grow and preserve the historic corridor.
Durham offers $10K for Fayetteville Street businesses, but owners say corridor needs more investment
Another record breaker for business expansions and job growth in Georgia
Gov. Brian Kemp and the state Department of Economic Development announced $35.2 billion in project investments for the fiscal year that ended June 30. That is up from $26.3 billion the prior fiscal year, which had also broken records.
Former Cowboys running back Emmitt Smith is sued by investor over wind farm project
NFL career rushing leader Emmitt Smith is being sued by a Native American investment company over claims that the former Dallas Cowboys running back and his business partners misappropriated a $2.5 million loan that was supposed to fund a wind farm pro...
A record fiscal year for business, job growth in Georgia
The economic boom continued in Georgia last year, with a second record-topping year of business investment and job growth.
Pa. city announces $600K investment to renovate business corridor
Three restaurants and a bakery have already committed to storefronts.
Congressman Langworthy Announces $76.2 Million Investment to Strengthen Rural Health Care
Southern Tier and Finger Lakes healthcare to benefit from “Rural Health Transformation Program” From the office of Congressman Langworthy, Congressman Nick Langworthy today announced a $76.2 million investment through New […]
$25M federal grant to upgrade technology, expand high-speed internet for rural health clinics
A major investment has been announced that will modernize Michigan healthcare.
Dodgers Still Searching for Answers to Tucker’s Collapse
A $240 million investment faces a baffling crisis as Kyle Tucker’s struggles at home defy logic, leaving the Los Angeles Dodgers scrambling to fix their star.
Sold: Sanford buys North Memorial Health
Following years of mounting financial pressure, North Memorial Health has reached an agreement to be acquired by South Dakota-based Sanford Health, backed by $600 million in guaranteed local hospital investments
Greystar Announces BMW Lease at Mid85 Logistics Park Near Spartanburg
Greystar, a global leader in rental housing, investment management, development, and property management, today announced a long-term lease with BMW North America at Mid85, its Class A logistics park in the Greenville-Spartanburg...
Protolabs Named to Business Insider’s America’s Most Innovative Businesses 2027 List
MINNEAPOLIS, September 04, 2026--Protolabs (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced it has been recognized as one of America’s Most Innovative Businesses by Business Insider. The digital manufacturer was recognized for its extensive library of patents for manufacturing technology, ongoing investment in research and development, and strong peer sentiment as a cutting-edge leader within the industry.
Global Business Travel Group (GBTG) to Be Acquired for $9.50: What Investors Should Know
Gabelli Investment Management Firm recently released its “ABC Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund benefited from a favorable merger-arbitrage environment in the second quarter of 2026, as global announced M&A value reached a record $2.85 trillion in the first half of the year, up 50% […]
CVS Health Ventures looks beyond healthcare for its next bets
CVS Health Ventures has evolved from a $100m venture unit into a broader investment platform combining financial discipline with a mandate to drive strategic change across CVS Health.
Purpose-built stadiums could unlock $1bn in revenue for women’s sports, new report finds
Finding a 'home' for women's teams can help take them to a new level on and off the field. Investment is needed, says a private fund
NSF launches three new science and technology centres
The move will see US$90M investment in transformative research
VIDEO: Campbell Opens $15M Health and Community Development Center
Explore the new Campbell Health and Community Development Center, a $15 million investment uniting health care, education, and resources.
Is Six Flags (FUN) Recalibrating Its Investment Story With an Arlington Move and 2027 Ride Push?
Six Flags Entertainment recently announced that it will continue investing in Carowinds and Carolina Harbor, with new attractions such as Rip Roarin' Falls set to open in 2027, alongside an ambitious slate of rides including Bakunawa and Werewolf Gorge across several flagship parks. The company also plans to move its corporate headquarters in 2027 from Charlotte to Arlington, Texas, consolidating leadership closer to its five Texas properties while maintaining a regional presence and ongoing...
More Georgia jobs as business investment tops record for second year
Georgia reports a record $35.2 billion in business investments and thousands of new jobs for the past fiscal year.
'The impact would be tenfold' | Mason business owners await improvements downtown
Mason business owners say the Mason Mile has been overlooked despite millions in city investment over nearly two decades.
SEC proposes reforms to political contribution rule for investment advisers
Wall Street's top regulator on Thursday proposed reforms to "pay-to-play" regulations intended to prevent investment advisers from winning business from public pension funds by making political contributions.
SEC Proposes Reforms to Political Contribution Rule for Investment Advisers
Sept 3 (Reuters) - Wall Street's top regulator on Thursday proposed reforms to "pay-to-play" regulations intended to prevent investment advisers from winning business from public pension funds by making political contributions. Under President Donald Trump, the U.S. Securities and ...
Fact check: Vance repeats Trump’s fictional ‘$19 trillion’ investment figure
President Donald Trump has for months been using a fictional economic figure. Vice President JD Vance echoed it on Thursday.
Meta Settlement Funds Could Be a Boost for Youth Mental Health
This is an exclusive BHB+ article. Social media has long been criticized for its potential role in the deterioration of children’s and young people’s
This Week in Jacksonville: Business Edition - Jacksonville growth draws Mesa Capital multifamily investment
Billionaire family offices back health care and biotech startups in August
The personal investment firms of titans like Stanley Druckenmiller are backing innovations in gene editing, drug discovery and more.
Backed By More Than $100M Investment: DEAG Founder Peter Schwenkow's New European Live & Family Entertainment Group
Peter Schwenkow is planning the launch of a new European live and family entertainment group, bolstered by up to €100 million of equity from Swiss private
Not Prime. Not Delivery. This Business Holds the Key to Amazon's Future.
Amazon Web Services is providing the growth Amazon needs to be a market-crushing investment.
Large data center project in Weld County clears its first hurdle
Global AI's 35-megawatt data center project on a former Kodak campus in Weld County won planning commission support Tuesday, advancing a project the company says could grow into a potential $2 billion to $20 billion investment.
Sutter Investment Helps API Families Access Health Services
Chronic conditions such as hepatitis B, diabetes and hypertension continue to affect many Chinese, Asian and Pacific Islander communities across San Francisco. Yet language, cultural and financial barriers can make it harder for people to access preventive care, find available resources and stay on top of their health. APA Family Support Services (APAFSS) is working […]
Intermountain Health Unveils Plans for New Intermountain LDS Hospital in Downtown Salt Lake City
Intermountain Health unveiled plans today for a new Intermountain LDS Hospital in downtown Salt Lake City, marking a transformational investment in the future of healthcare for Utah residents and reaffirming a commitment to serving the community for generations to come.The new hospital will be located on an approximately eight-acre site at 745 S...
Entertainment Unleashed: Sphere Entertainment’s (SPHR) Innovative Approaches
Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q2 2026 investor letter. The letter can be downloaded here. Select Growth Fund targets U.S. businesses driving significant structural change through disruptive innovation. The fund returned 23.2% in the quarter, outperforming the Russell 1000 Growth Index’s 16.7%. U.S. large-cap growth equities rebounded […]
August Monthly Review: ChatGPT In Epic
Death, taxes, another frontier lab healthcare launch inspiring truly insane LinkedIn takes. As much as I want to stay away, I repeatedly am the crewman unplugging his ears whenever we pass these sirens. So it’s not the first and probably not the last time we dial up the typewriter rather than tie ourselves to the mast. The full blow-by-blow timeline: Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe The End of the Standalone PHR (Jan 8): ChatGPT Health arrives for consumers, at the time powered by b.well. I was bullish on the approach in that the best way for the PHR to finally solve distribution was to meet consumers were they already are (i.e. When Horizontal Meets Healthcare (Jan 9): OpenAI for Healthcare puts out the shingle for enterprises, with SharePoint ingestion standing in for the EHR integration the product actually needed. Another One: Anthropic’s Healthcare Debut (Jan 16): Claude's version, on HealthEx rails instead of b.well, with Agent Skills for FHIR development as the one true vertical-specific investment. ChatGPT for Clinicians: The Trap Sprung (Apr 24): OpenAI filled in the missing GTM middle with a free product for verified clinicians, effectively peeling the enterprise wrapper off ChatGPT for Healthcare and taking the PLG fight directly to OpenEvidence. OpenAI’s Second Attempt at Health (Jul 31): a relaunch of their patient specific app, now branded Health in ChatGPT, where the privacy partition came out, the connectors thinned, and b.well disappeared in favor of first-party FHIR work against a smaller network Beyond a Shingle So what was announced now? Today, we’re introducing a new electronic health record integration that brings authorized patient context from Epic into ChatGPT for Healthcare, along with the Healthcare Public Data plugin for direct, structured access to official healthcare datasets like PubMed, DailyMed, and CMS Coverage. Together, these capabilities bring ChatGPT closer to the systems and sources healthcare teams trust, while supporting the controls and compliance healthcare work requires. The core portfolio is unchanged from prior announcements we delineated and discussed (aside from the relaunch of patient-facing). Since trade publications still seem to be confusing them by using the wrong names: Enterprise sales motion: ChatGPT for Healthcare Protecting their core product / PLG: ChatGPT for Clinicians Consumer/patient-facing product: Health in ChatGPT So really, this is a feature release (specifically for ChatGPT for Healthcare when it comes to EHR integration). What’s cool about it, though, is that we are moving beyond just putting out a shingle. Everything in the January enterprise launch was horizontalizable: Horizontal tech companies thus generally start verticalization with their “putting out a shingle phase”. Telling the world you’re open for business as a horizontal tech company reliably attracts early inbound interest from buyers who are already trying to force-fit horizontal tools into domain-specific workflows and are eager for any signal that the vendor intends to support their use case more directly. Nothing was really vertical specific, which is exactly what you'd expect from the ultimate hypergrowth horizontal company dipping their toes into specific industries. But eventually you have to stop changing the sign on the door and start changing the product. Can you guess where the horizontal product was going to run out of road? This is the core dilemma writ large: verticalization requires differentiation, while scale economics of consumer and horizontal push toward unification. I’ve buried the lede so deep here it will be painful to some readers, but what should be shocking to no one is that my perspective is that EHR integration is the only path that meaningfully resolves this tension for ChatGPT for Healthcare. Integration with Microsoft Sharepoint is fine, but it is categorically insufficient for any product that hopes to influence clinical decision-making. SMART Money Well here we are, eight months later! Real vertical investment has begun, which surprised a few people. One friend in the industry messaged me: “Absolutely no way Epic gave ChatGPT API access.” Looking forensically at the announcements, the integration is notably read-only across appointment notes, laboratory results, medications, and specialist documentation. So while I’m not a betting man, I'd wager the house this is a SMART on FHIR launch: That sounds a lot like USCDI! The recommended path for the workflow they outline would be SMART on FHIR Their Health AI lead’s post is evocative of both standalone and EHR launch SMART, which another termed “ChartGPT” and “EHR Plugin” The implementation burden for SMART on FHIR is the lowest of the available integrative paths This is the team who literally did patient-facing SMART on FHIR with Epic last month Most importantly, if you’re a horizontal company, you generally still haven’t taken the full plunge and thus (overly) value reusability. SMART on FHIR is the logical compromise: healthcare-specific enough to matter, but standardized enough to reuse. Nobody Asked Judy Another friend asked “I thought they had to go to each health system, or did they go direct to Epic and now health systems opt in?” Given the trust paradigms in healthcare, this functionally cannot be Epic hoovering up all the data for OpenAI and shoving ChatGPT in their customers’ faces (or they would revolt). However, I do believe the aforementioned terrible coverage by TechCrunch and other outlets is probably responsible for that question, given the 325 million reference. When using FHIR as a business associate to an Epic customer, there is no EHR gatekeeping to speak of, as that isn’t how fhir.epic.com works: You register an app You pick your APIs You test against the sandbox APIs You list as “Ready for Production” Hospitals pick your app You test and go live with them Bluntly, nobody had to say yes or no in Verona (nor were they given the chance). Vendor Services (their next developer tier up that I doubt OpenAI is using quite yet in this initial release) certainly has contractual paperwork that some resent, but even there, the twin pressures of mounting antitrust and information blocking make outright gatekeeping increasingly fraught. My friend’s sentiment is, to me, representative of a broader industry neurosis, perhaps a sort of scar tissue of prior eras: people assume the gate is still there and never actually try the door. There are certainly other ways Epic (and any EHR) can put its thumb on the scale, but they are not so dumb as to stand in front of a federally mandated API and play bouncer at this exact moment in time. So I think they can and probably should go deeper, as this release is at best parity and at worst behind vertical-specific competition. OpenEvidence did a basic SMART launch with Sutter Health in February, allowing for more convenient evidence search by providers. They then add patient-context (the equivalent SMART on FHIR flow to what we see here) when Cedars-Sinai went enterprise-wide in May. UpToDate has four distinct applications across deeper workflows like patient engagement listed in Epic Showroom and announced a partnership with Epic to power Art at UGM Abridge and other ambient scribes have invested deeply into the deepest bidirectional clinical copilot workflow with integrations well beyond SMART on FHIR. In that light, the “Who is OpenAI primarily targeting here?” is clear. This release brings them into striking distance of OpenEvidence, but not the others quite yet. They are the only one of the three you can reach without building something truly Epic-specific. When will they go further? Competition is a great motivator to overcome the horizontal demons and start building things that can’t be reused: not across industries, not across EHRs, maybe not past the customer you built them for. That’s the price of actually verticalizing. The question is if and when OpenAI will be willing to pay it. Month in Review Here is the monthly review. As a reminder, this is a regular round-up of the month’s posts and other content to surface things you may have missed across regulation, litigation, interoperability, and beyond. AI assistance is used in these bullet summaries so I can focus on articles. Articles Published: None this month Video Content: The Information Exchange: Standards-based Thruple Edition (Aug 14): Back to school for us too, with Brad reporting in from the CMS Health Tech Ecosystem’s one year anniversary in DC. We get into the January CMS-0057 deadline, the fall rulemaking reading list, and why enrollment still keeps most apps off FHIR. The Information Exchange: Epic Dúnadan Edition (Aug 25): A UGM roundup with Ryan Brickner joining for the first time to check our takes against what the building actually thinks. Rangers, Ergo sitting on top of EHI, and a down-market lineup that needs some cuts. Regulatory: Stacked Deck, Bad Hand (Aug 05): ONC’s website refresh took the entire HIT Policy Committee record with it, so I rebuilt the archive and went looking for the regulatory capture story everyone assumes is buried in there. Stacking the deck and winning the hand turn out to be very different things. The Sixth Generation of Patient Access (Aug 19): A quick catalog of the five generations of patient access we’ve layered on since HIPAA, and the two candidates now competing to be the sixth. One is planned. The other is the market routing around the plan entirely. Court cases: Three Cases Walk Into a Docket (Aug 06): Two surprise settlements cleared the board in a single week, and then Judge Maddox dropped ninety-four pages on Vyne v. Henry Schein. The sleeper is a DMCA holding that makes direct-to-database a considerably riskier business model. Epic v. Health Gorilla: Into the MDL (Aug 10): Nine class actions are headed to Miami, and the Panel signaled it wants to bring the case that spawned them along too. That would leave Epic arguing the requests were obviously fraudulent in one courtroom and unknowable in the other. Amazon v. Perplexity: Agents Are Legalized! (Aug 11): The Ninth Circuit vacated the injunction against Comet, holding that the user is the one accessing the servers rather than the company that built the agent. A real win for agentic access, and a much narrower one than the headline suggests. Veeva v. Epic: Come At Me, Bro (Aug 26): Epic’s response brief wants the dismissal affirmed and, unusually, wants the opinion published as precedent. Buried in it is Epic’s own description of what its non-competes actually prohibit, which current and former employees should read closely. EHRs: The Contract Epic Would Never Sign Today (Aug 04): A 1999 SEC exhibit catches Epic licensing nearly its entire product line, Tapestry included, to the company that became TriZetto. The marketing services menu attached to it is the part that will make you blink. Forecast from Verona (Aug 07): The Epic Almanac makes one argument six different ways: the AI is only as good as the networks behind it. Emmie headlines, Art’s context stack is the most ambitious part, and Penny finally gets an autonomous coding date on the calendar. Works With Epic MyChart (Aug 17): Epic’s first new Showroom category since the death of Workshop certifies hardware instead of software, badge on the box and all. Made for iPhone, but for blood pressure cuffs, and rough news for anyone selling the RPM stack sitting in between. UGM Hot Takes 2026 (Aug 20): Everyone else covered the AI announcements, so I went after Savvy deleting the payment gateway, Rangers as Boost with the timer removed, and a down-market lineup with too many entries. Plus the Health Grid tidbits I cannot help myself on. MyChart Central Grows Up (Aug 24): Device data and Emmie turn Epic’s identity hub into a full consumer platform, which is both a logical answer to ChatGPT and a bit of a mistake. It also happens to be the best scraping target Epic has ever shipped. Industry Analysis: The Wrong Yardstick (Aug 12): Vertical software keeps getting judged against Superhuman and Notion, which is the wrong bar entirely. Your user is comparing your product to a whiteboard and forty phone calls before lunch. Primitives vs. Abstractions (Aug 27): Developers want building blocks, systems of record prefer to hand out business logic, and both sides have a real case. There’s no test from the outside that separates the engineering reason from the competitive one, which is why this keeps ending up in court. Cross-industry Comparisons: The Two Kinds of Platform Power (Aug 18): Attention power and record power are different problems that keep getting handed the same regulatory toolkit. Congress’s latest swing at Big Tech shows both what’s possible and where it falls apart. The Dogs of (Platform) War (Aug 21): A CourtListener alert turned up a property management fight with healthcare’s exact shape and none of the Cures Act. Shell prospects, ghost accounts, a notetaker bot that came back to haunt someone, and a lawyer arguing both sides of the same theory in two states. Fractals All the Way Down (Aug 31): Yardi dominates property management right up until you zoom into one segment, where AppFolio owns it outright and Yardi doesn’t appear at all. Where you draw the line around a B2B software market is about to decide an awful lot of cases. Other News: If Judy Had the Courage (Aug 13): A short eulogy for the era when software was allowed to look insane: WinAMP, bold colors, and everything the grey chatbot era has taken from us. External Media: Portland Monthly Health Tech Meetup: Erin O’Brien channeled my own feelings - maybe it’s just because it’s August and beautiful, but the monthly edition of the PDX Health community meetup was a ripper. Make sure to reach out if interested to join for the next one. STAT’s Coverage of Epic This Month: Brittany Trang of STAT did a fantastic job of breaking the FTC investigation that’s been lurking, as well as UGM related coverage, so I had to give her her wish of a meme. Fall Conferences: I’m pumped to be kicking off my fall conference season in NYC at Nabla Accelerate next month, which Chrissy provided the link to apply for. Here’s the rest of my schedule in case you want to meet up: Commonwell (Redwood Shores, CA): Oct 13-14 Open@Epic (Madison, WI): Oct 21-22 eHealthExchange (Austin, TX): Oct 27 Sequoia Project (Austin, TX): Oct 28-29 HLTH (Vegas): Nov 15-18 RSNA (Chicago): Nov 29-Dec 3 Posts I Liked: HTI-6 Should Unbundle API Certification: Josh Mandel makes the case that HTI-6 should split (g)(10) into separate authorization and data certifications, so a PACS or a genomics platform can certify only the role it actually performs. Imaging is the urgent example, but the structure solves a much bigger problem. On implementing ePrior Auth with Epic: Scott Rossignol’s field notes from a live ePrior Auth build on Epic, including the two app registrations nobody warns you about and the CPT mapping problem waiting at the end. CMS-0057 implementations are going to be such a beast. Healthcare point solutions are starting to look a lot like streaming services: Spencer Dorn runs the cable-to-streaming arc against health IT and lands squarely on the bundling half of the cycle. Bundling can be good! It can also be bad! Life is nuanced. Health API Guy is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
New investment into perinatal care could help Iowa mothers with mental health concerns
A Coalville mother recounts her experience with postpartum psychosis, as Iowa invests federal funding to improve access to perinatal mental health resources.
Former Florida governor hopeful hauled out of county meeting after protesting Isarael investments
James Fischback was forcibly removed from a Miami-Dade commissioners meeting after protesting the county's raised investment limit in Israel bonds.
Johnson’s starring role in World Business Chicago videos draws ethics hearing
The videos feature Johnson narrating investments his administration has made in city neighborhoods.
Johnson’s starring role in World Business Chicago videos draws ethics hearing
The videos feature Johnson narrating investments his administration has made in city neighborhoods.
Medtronic invests up to $80M in medtech company Pi-Cardia with a potential buyout on the table
Less than a year after investing heavily in Minnesota-based Anteris Technologies, Medtronic has announced a new strategic investment in Pi-Cardia. The TAVR technology at the heart of this investment is Pi-Cardia's FDA-approved ShortCut device.
Scottsdale investment firm acquires Shasta Pools, plans nationwide growth
It was more than a year ago when Jeff Thiessen, president of Scottsdale-based Dansons Capital Group, was in the middle of having a pool built in his backyard when the builder couldn't finish the job.
UNCW Welcomes New Research Vessel to Advance Marine Science and Education
UNCW officially welcomes the 78-foot research vessel Osprey (R/V Osprey) to its fleet, marking a significant investment in the university's commitment to advancing coastal and marine research, education and stewardship.
Grand Canyon Education (LOPE): A Steady Cash-Generating Business Ignored in a Speculative Market
Riverwater Partners, an investment management company, released its ‘Small Cap Strategy’ Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchmark experienced one of its strongest risk-on rallies in recent memory, although the strategy remained ahead year-to-date. The quarter was defined […]
Inexpensive new cars are becoming tougher and tougher to find
Automakers in recent years have decided that the lower end of the market is no longer worth the investment.
NSF launches three new Science and Technology Centers with $90M investment in transformative research
The U.S. National Science Foundation is investing $90 million over five years to support three new NSF Science and Technology Centers (NSF STC). These centers will advance American leadership in science and technology, strengthen the nation’s STEM workforce, and accelerate innovation in fields ranging from artificial intelligence and biotechnology to fusion energy and robotics., , , , The three centers will bring together researchers from universities, national laboratories, industry, and oth...
Trump: 90% of prescription drugs covered by 'most favored nation' price deals
Several of the companies that agreed to lower drug prices also announced U.S. research and development investments Monday
Nike, RAJ Epicenter Week And The Business Of Women’s Sports
Portland’s Nike Global Sport Summit and RAJ Sports Epicenter Week brought 500+ leaders together to explore investment, infrastructure and the future of women’s sports.
Kroll Introduces APEX to Drive Measurable Business Outcomes from AI Investment
/PRNewswire/ -- Fal.Con 2026 – Kroll, the leading independent provider of global financial and risk advisory solutions, today announced the launch of Kroll AI...
City and URA Announce $600,000 partnership to Renovate Façades
As part of Mayor O’Connor’s Main & Main initiative, he and the Urban Redevelopment Authority of Pittsburgh (URA) have announced a new $600,000 strategic investment in the East Ohio Street business district.
Meitav Investment House Announces Immediate Report Concerning Selected Business Data for July 2026
/PRNewswire/ -- Meitav Investment House (TASE: MTAV) announced today that further to the Company's immediate report dated March 2, 2026 (Reference No....
Who is behind Monarch Collective? The 10,000-fan bet that changed women’s soccer investment
Understanding the private-equity fund behind several successful women's sports ventures
Trump says Venezuelan oil will lower gas prices. Analysts disagree.
Analysts say Venezuela needs years of investment to boost oil production, and that 65 billion barrels won't materialize overnight.
Data center growth could outpace power generation
Dominion Energy confronts rising power demand from nearly 650 data centers in Virginia, straining the grid and prompting infrastructure investments.
UK science breakthroughs are being exploited overseas, minister says
Chris McDonald says British discoveries are being developed abroad because start-ups cannot find enough investment or laboratory space at home
Colorado Sues EarnIn For “Immoral, Unethical, Oppressive and Unscrupulous” Business Practices
Hey all, Jason here. When this hits your inbox, I should be en route to the airport — not to go anywhere myself, just to pick up my better half. I must admit, it’s been strange to be home alone (well, with two dogs) for two weeks! Really lets me “optimize” to spending more time on reading/writing/working, whether that’s healthy or not! Looking forward to getting back into a (somewhat) more balance routine. Subscribe or Support by Upgrading Compare Notes With the People Who Built Modern Fintech Partner content: Remitly CEO Sebastian Gunningham. Increase founder Darragh Buckley. Linda Du, Co-founder & President at Valon. They’ll unpack the decisions behind building and scaling major financial products: what they got right, what broke, what they would do differently, and how AI and new infrastructure are changing the operator playbook. Most events tell you where fintech is going. NerdCon puts the people who built the present in the room and asks them what comes next. Expect an operator-led conversation grounded in real products, real trade-offs and lessons earned the hard way. Fintech Business Weekly readers save 20% on Regular tickets with code FBW20 before standard pricing ends September 11. Meet the Builders Things To Know & Other Good Reads Advent and Stripe Abandon $50 Billion Pursuit of PayPal (Bloomberg) Trump Family’s New Crypto Bank Is Backed by Abu Dhabi Sheikh (Wall Street Journal) The multiplying risks of financing data centres (FT) Let the Bond Market Speak (Wall Street Journal) Did we waste a crisis? Modest proposals to reform deposit insurance. (Fintech Takes Banking) Untangling Guggenheim: How Private Credit Built Its Own Universe (Net Interest) The Hater’s Guide To Circular Financing — Part One (Ed Zitron) Fiat Ventures Rebrands to FGV Capital, Announces $35M Oversubscribed Fund II (BusinessWire) Socure Announces Strategic Growth Investment at $5.2B Valuation and Acquires Agentic Operations Platform Fravity (Socure) Listen: When Consumer Protection Disclosures Work Too Well (Consumer Finance Monitor Podcast) Colorado Sues EarnIn For “Immoral, Unethical, Oppressive and Unscrupulous” Business Practices When Andreessen Horowitz led EarnIn’s $39 million Series B in 2017, Alex Rampell, a partner at the storied venture capital firm, described EarnIn’s small-dollar advance product as “free,” relying on “entirely on voluntary contributions instead of fees.” Rampell favorably compared EarnIn’s approach to typical payday loans, writing, “Payday loans historically have had the potential to be a slippery slope for consumers into financial distress: opaque systems and steep fees that are hard to repay and set individuals back further than where they started. For many Americans living paycheck to paycheck, that kind of slide into debt can be extremely difficult to recover from.” But EarnIn’s product — which, the company says, isn’t a “loan,” legally speaking — ends up being anything but free for most users. While it is technically possible to take a no-fee advance from the company, most users incur “Lightning Speed” (instant funding) fees and/or ostensibly optional tips that combined can equate to annualized percent rates that can reach over 1,000%. With an average term of 9.77 days, even fees and tips that are small on an absolute dollar basis are equivalent to high APRs on an annualized basis. A lawsuit filed last week by Colorado Attorney General Phil Weiser against EarnIn describes the company and its product and business practices quite differently than Andreessen’s Rampell; “EarnIn’s business practices are unfair because they are immoral, unethical, oppressive and unscrupulous,” the complaint, filed in District Court in Denver, Colorado, says. EarnIn’s marquee product, Cash Out, isn’t a loan, the company says, as Cash Out is not “[f]orward [l]ooking” because “[t]he money is transferred based on earnings to date,” does not carry a mandatory fee to access funds, and is “non-recourse,” meaning EarnIn cannot pursue recovery from users who don’t repay advanced funds. EarnIn is sometimes referred to as an “Earned Wage Advance” service. Though, unlike some others in the broader category, EarnIn does not integrate with employers’ payroll or time and attendance systems. Rather, EarnIn attempts to verify a user’s income and employment, by examining direct deposit transaction data in their linked external bank account, by using GPS location and Bluetooth data to estimate a user’s time spent at work, if they work in a fixed location, and/or by having a user provided a work email address. While repayment is theoretically optional, as EarnIn would have no recourse, such as reporting non-payment to the credit bureaus or a collections agency, this is anything but clear to users of the EarnIn app, Colorado’s complaint argues. During the process of taking a Cash Out, users must agree to a preauthorized debit of the amount advanced, plus any expedited funding fee and/or tips. Though users technically can revoke this ACH authorization, the fact that they have this right isn’t presented to users during the Cash Out process, but rather is included in linked terms and conditions few users are likely to actually read. And users who do wish to revoke their ACH authorization must do so three or more days before the scheduled transaction date by emailing EarnIn’s customer support. Similarly, EarnIn’s marketing claims that it carries “no interest” and “no mandatory fees” is technically true, but is not the reality for many of the app’s users, the Colorado complaint argues. Further, EarnIn has extensively marketed to users the ability to “access your pay today,” to get “instant” funds, and to get funds “the same day you work” — when, in reality, this speed of access was only possible by paying the additional, undisclosed Lightning Speed fee. The Colorado complaint highlights this contradiction specifically, noting: EarnIn tells consumers that they can ‘Make any day payday with EarnIn’ and that there no ‘hidden’ or ‘mandatory fees.’ For a consumer to access their pay on the same day requested, they would have to pay the Lightning Speed fee. In the fine print of the advertisement EarnIn discloses that ‘[f]ees apply to use Lightning Speed,’ a direct contradiction to the larger text of the advertisement, and a fact that would not be immediately understood by a consumer as ‘Lightning Speed’ is not defined nor explained. Like other small-dollar lending services, rather than explicitly charge interest, EarnIn collects a markup on the optional Lighting Speed fee, which, given the nature of the transactions, many users opt for, as well as offering users the option to leave “tips.” EarnIn leverages either Real-Time Payments (RTP) rails or push-to-card via debit rails if a user opts for the optional Lightning Speed. But while these capabilities cost EarnIn, on average, $0.075 or $0.20 per transaction, respectively, EarnIn charges users significantly more. Initially, EarnIn charged as little as $1.99 for Cash Outs up to $24. But EarnIn has hiked these fees multiple times, and now charges $4.99 for Cash Outs up to $75 and $6.99 for those over $75. According to the Colorado complaint, EarnIn leverages “dark patterns” to manipulate users and to make it more difficult to avoid tipping. Examples of these “road blocks” highlighted in the complaint include: As of 2023, in the EarnIn app, a consumer attempting to get a loan under the default settings had to make at least eighteen separate taps to complete the transaction and reduce the tip to $0. There is an alternative method to leave a $0 tip, via the “Custom tip” feature, but EarnIn made this option difficult to access by visually deemphasizing it and positioning it near devices’ “home” button. Using language and imagery such as “Tip to pay it forward,” “Your generosity supports the service + helps,” “Your tips make a difference,” and “[t]he APR for this cash out is 0%. Your tips help support us.” While Lightning Speed and tipping are, in theory, both optional, in practice, users nearly always ended up paying something. According to the Colorado suit, users were charged either a tip or an expedite fee for more than 92% of transactions, with an average APR of nearly 388%. And, although the advances are “non-recourse,” EarnIn successfully collects on nearly all transactions — 99.18%, according to the complaint, which, Colorado argues, “demonstrat[es] that EarnIn’s advances function as high cost loans, not voluntary payments.” The share of EarnIn users incurring fees — despite the product being marketed as 0% APR — is hard to reconcile with Andreessen investor Rampell’s favorable description of EarnIn vs. “opaque systems and steep fees” associated with payday loans, which, Rampell says, can be “extremely difficult” for borrowers to extricate themselves from. According to Colorado’s suit, EarnIn’s Cash Out product “trapped many consumers in extreme cycles of high-cost reborrowing.” The suit gives an example of one consumer in the state, who took out a whopping 1,151 loans, paying a total of $4,038.50 in Lightning Speed expedited funding fees on loans that averaged the equivalent of 1,421% APR. Another Colorado user, the suit says, took out 1,033 loans, paying $8,561.22 in tips and fees at an average APR of 1,539% . These types of usage patterns demonstrate “the severe and repeated financial harm caused by EarnIn’s illegal lending model,” the Colorado complaint argues. In aggregate, from January 2023 through July 2025, EarnIn extended 3.1 million loans to 56,778 users in Colorado — an average of nearly 55 transactions per person during the time period. EarnIn lent more than $300 million and collected more than $16 million from Colorado users in Lightning Speed fees and in tips. Ultimately, the Colorado complaint argues that “EarnIn’s Cash Outs are loans under Colorado law, and EarnIn’s contention that its product is not a loan based on its disclaimer of any legal repayment obligation lacks any real-world significance given how the Cash Out transactions actually operate in practice.” Colorado further argues that “EarnIn was not working with companies here in providing consumers with funds but acted as a third-party lender and charged illegally high rates, used deceptive design strategies to extract some charges, and trapped consumers in repeat borrowing. Colorado will continue to stand up for consumers and hold companies accountable when they violate our credit laws or attempt to evade them through misleading practices.” Colorado’s suit alleges EarnIn assesses finance charge in excess of that permitted by Colorado law, that EarnIn failed to make legally required disclosures to Colorado borrowers, that EarnIn made supervised loans to consumers without obtaining the requisite license, that EarnIn violated the state’s Deferred Deposit Loan Act, that EarnIn engage in unfair and deceptive trade practices, and that EarnIn made false or misleading statements concerning price. The suit seeks a court order enjoining EarnIn from violating relevant Colorado laws, for EarnIn to refund amounts charged in excess of state law, fees, costs, and penalties, and other relief the court deems to be just. Fintech Business Weekly is made possible by the generous support of paying subscribers — bringing you independent analysis of banking, fintech, and crypto without fear or favor. You can support my work by becoming a paying subscriber if you aren’t already. Paying subscribers enjoy: access to the entire archive of nearly six years of newsletters extended versions of the weekly newsletter, with additional content and analysis and (for founding member tier) quarterly personal 1:1 fintech Q&A / strategy calls with me, tapping into my unparalleled knowledge of the intersection of banking and fintech and experience working in the sector, including helping to launch Goldman Sachs’ retail bank Marcus Support Fintech Business Weekly You can also support Fintech Business Weekly by sponsoring a newsletter or podcast, putting you in front of 93,000+ of the most influential decision makers in banking, fintech, and crypto. Learn more about sponsor opportunities or request a media kit by dropping me an email. Q2 Quarterly Banking Profile: Five Quick Takeaways The FDIC released its quarterly banking profile, which is always worth a read, for the second quarter. The profile provides an aggregate snapshot about the overall health of the 4,238 institutions whose deposits are insured by the FDIC, who, collectively, hold more than $26 trillion in assets and saw a total net income of more than $90 billion in the second quarter. Net income was up 12% vs. Q1 2026, with lower provisions and realized gains on securities helping to drive the improvement, somewhat offset by increases in non-interest expense and applicable income taxes. Overall net interest margin was basically flat quarter over quarter (up 1 basis point vs. Q1 2026), though community banks saw NIM grow by 10 basis points, to 3.81%. Unsurprisingly, given that interest rates haven’t changed, unrealized losses on securities changed little, edging up slightly to $326.7 billion vs. $325.1 billion in Q1 2026. Aggregate credit quality has remained benign, with asset quality actually improving slightly in Q2. Overall, institutions reported a 9 basis point decline in their past-due and non-accrual rate, to 1.44%. Net charge off rate also declined by 2 basis points, to 0.57%. And finally, the FDIC’s deposit insurance fund stands at $161.1 billion, making the DIF reserve ratio 1.48% — above the statutory minimum of 1.35%, but still below the designated target reserve ratio of 2%. [Paid Subscriber Exclusive] Nissan Withdraws ILC App, State Associations Plan BankChain Alliance, FDIC Defines “Unsafe or Unsound Practice” For First Time Automaker Nissan withdrew its application to charter a Utah industrial loan company and its corresponding application to the FDIC for deposit insurance last week, on August 19th. Nissan’s application had been outstanding for more than a year, as it originally applied in June 2025. Recent applications to the OCC to form national banks have been decisioned, one way or the other, substantially more quickly than has historically been the case.
Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 183,455 Dave & Buster's Entertainment, Inc. $PLAY
Connor Clark & Lunn Investment Management Ltd. bought a new position in Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 183,455 shares of the restaurant operato
As VR Gaming Looks for New Footing, the Out-of-Home XR Entertainment Space is Still Building
The investment and development community are constantly striving to find the next profitable sector in XR, turning to new business opportunities following a turbulent time in the consumer VR gaming space. One area of interest is in out-of-home XR attractions, known widely in the industry as Location-Based Entertainment (LBE) XR. The sector deploys XR as […]
Why Alphabet (GOOGL) Is Proving AI Can Strengthen Its Search Business
Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming the 13.87% gain for the Russell 1000 Value Index and the 15.20% return for the S&P 500, while […]
Minnesota AG announces oversight deal allowing North Memorial-Sanford Health merger to advance
Terms of the agreement include $600 million in investments in North Memorial’s Maple Grove and Robbinsdale hospitals, and maintaining the Level 1 trauma center in Robbinsdale for at least 10 years.
Georgia’s 87 rural hospitals to receive $93.3 million for health upgrades from US government
Nearly 90 hospitals in Georgia will get a piece of a new $93.3 million investment from the Trump administration.
Honduras Joins the Alliance for Primary Health Care in the Americas
Tegucigalpa, Honduras, August 27, 2026 (PAHO) —Honduras has joined the Alliance for Primary Health Care (PHC) in the Americas, a regional initiative led by the Pan American Health Organization (PAHO), the Inter-American Development Bank (IDB), and the World Bank to support countries in strengthening primary health care through coordinated investments, innovation, and technical cooperation.
Business Briefs: Aug. 28, 2026
UMassFive welcomes new community engagement pro HADLEY — UMassFive College Credit Union has hired Kelley Jewell as its community engagement coordinator. This newly created position reflects UMassFive’s continued investment in community engagement and expands the credit union’s ability to deliver financial wellness programs, strengthen community partnerships and support volunteer efforts throughout the Valley. In this […]
How Innovation Could Reshape Chemistry by 2050
Chemistry and chemical engineering are fundamental to technologies that could revolutionize energy production, quantum computing, and materials and manufacturing over the coming decades. At a recent workshop, participants from academia, industry, and government considered the future of the chemical sciences, exploring scientific challenges that researchers should prioritize, where strategic investments could enable breakthroughs, and how the chemical sciences community can prepare for emerging capabilities.
Corewell Health Announces $1.7 Billion Investment to Build Stronger Healthcare for Michigan
Major projects in Grand Rapids and Troy will expand access, modernize patient care GRAND RAPIDS and TROY, Mich., Aug. 27, 2026 /PRNewswire/ -- Corewell Health™ is making a $1.7 billion...
There are a record 3,795 billionaires in the world right now—and just like Jeff Bezos, their favorite investments are sports and philanthropy
Billionaires from Microsoft CEO Steve Ballmer to businessman Robert Kraft are spending their fortunes buying sports teams and funding charitable causes.
Utility investment analysts ding Indiana amid 'political intervention,' potential profit cuts
Energy companies warn of the potential impacts of investor distrust as Gov. Mike Braun calls on them to "deliver" to earn higher profits.
New youth crisis center opens in Belmont County with $5.3M state investment
Children and families in southeastern Ohio now have a new option for behavioral health care closer to home with the opening of a youth crisis stabilization cent